ConcertoHealth recently announced the appointment of noted health policy expert Mark D. Smith, M.D., M.B.A, to its board of directors.
By Brian Gormley
September 24, 2015
Dow Jones VentureWire
Amid a jump in investment in reproductive-health technologies, CerviLenz Inc. has restructured as Lucina Health to provide a broader solution to the problem of preterm births.
To read the entire article, click here. VentureWire subscription required.
ConcertoHealth, Inc. (formerly Fidelis SeniorCare) today announced it has divested its insurance assets to focus solely on expanding its innovative healthcare delivery model for dual-eligible Medicare and Medicaid patients.
Arboretum Ventures, a leading healthcare venture capital firm, today announced the closing of its fourth fund with capital commitments of $220 million, which nearly doubles the firm’s capital under management to $450 million.
Crain’s Detroit Business Article
Arboretum’s Latest Fund is Largest in Michigan Venture Capital History
Delphinus Medical Technologies Inc., the leader in advanced breast ultrasound technology, has announced that it has secured an unprecedented venture round of $39.5 million.
The CARILLON® Mitral Contour System® is projected to be a cost-effective treatment option when compared to a typical regimen of optimal medical treatment (OMT), the present standard of care for functional mitral regurgitation (FMR).
NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVE™) platform technology to treat endourological conditions, is pleased to announce it has received FDA 510(k) clearance of the company’s Rezūm® System to treat BPH.